Elizabeth A. Barrett - 03 Feb 2020 Form 4/A - Amendment Insider Report for UroGen Pharma Ltd. (URGN)

Role
Chief Executive Officer
Signature
/s/ Jason Smith, Attorney-in-Fact
Issuer symbol
URGN
Transactions as of
03 Feb 2020
Net transactions value
$0
Form type
4/A - Amendment
Filing time
12 Jul 2021, 18:57:46 UTC
Date Of Original Report
14 May 2020
Next filing
12 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction URGN Ordinary Shares Options Exercise +8,807 +7.2% 131,043 03 Feb 2020 Direct F1, F2
transaction URGN Ordinary Shares Options Exercise +8,807 +6.7% 139,850 03 Mar 2020 Direct F1, F2
transaction URGN Ordinary Shares Options Exercise +8,807 +6.3% 148,657 03 Apr 2020 Direct F1, F2
transaction URGN Ordinary Shares Options Exercise +8,808 +5.9% 157,465 03 May 2020 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction URGN Restricted Stock Units Options Exercise $0 -8,807 -4.2% $0.000000 202,570 03 Feb 2020 Ordinary Shares 8,807 Direct F1, F2, F3
transaction URGN Restricted Stock Units Options Exercise $0 -8,807 -4.3% $0.000000 193,763 03 Mar 2020 Ordinary Shares 8,807 Direct F1, F2, F3
transaction URGN Restricted Stock Units Options Exercise $0 -8,807 -4.2% $0.000000 198,956 03 Apr 2020 Ordinary Shares 8,807 Direct F1, F2, F3
transaction URGN Restricted Stock Units Options Exercise $0 -8,808 -4.8% $0.000000 176,148 03 May 2020 Ordinary Shares 8,808 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 14, 2020, the reporting person filed a Form 4 that inadvertently reported that a total of 35,229 shares vested on May 3, 2020. In fact, the shares vested monthly from February 3, 2020.
F2 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F3 On January 3, 2019, the reporting person was granted restricted stock units ("RSUs") representing 317,065 ordinary shares. 1/3rd of the RSUs vested on January 3, 2020, with the balance vesting in equal monthly installments thereafter over a period of three years.